Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug-Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of ISIS 681257 40 mg Subcutaneous Injections On The Pharmacokinetics And Pharmacodynamics Of Clopidogrel In Healthy Subjects

Next Previous
Trial Profile

Drug-Drug Interaction Study To Evaluate The Effect Of Multiple Doses Of ISIS 681257 40 mg Subcutaneous Injections On The Pharmacokinetics And Pharmacodynamics Of Clopidogrel In Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2018

At a glance

  • Drugs IONIS APOa-LRx (Primary) ; Clopidogrel
  • Indications Hyperlipoproteinaemia
  • Focus Pharmacokinetics
  • Sponsors Akcea Therapeutics

    • Most Recent Events

    • 03 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 19 Feb 2018 Status changed from recruiting to active, no longer recruiting.
    • 08 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top